Health services support - New Born and Women's health
- GynocularTM Study
- Point of Care HIV-1 Diagnosis to Improve Rates of ART Initiation among Infants (CDC Detect Study)
- Cervical cancer screening (Using VIA, HPV testing, Gynocular)
-
Referral for Cervical Cancer treatment
-
The named services are expected to provide information about:
- the estimate the sensitivity and specificity of the Gynocular, HR-HPV and VIA when used as a stand-alone test to detect CIN2+ among WLHIV.
- the optimal cut-offs for the Swede Score in WLHIV
- co-infections of premalignant and malignant disease (STIs/HR-HPV)
- the capacity of telemedicine to support quality imaging and efficacy of the Swede score in cervical cancer screening
- Artificial Intelligence algorithms to detect cervical intraepithelial lsesions of the cervix grades 2+
- the cost and cost-effectiveness of the VIA; Gynocular™ colposcope and HPV tests for Cervical Cancer screening among WLHIV,
-
The named services are expected to provide information about:
- Identify high-risk Mother Infant Pairs and conduct contact tracing to schedule appointments
- Make home visits to provide Early Infant Diagnosis (EID) using the Alere™ q HIV-1/2 Detect Point of Care platform
- Facilitate linkage to ART clinics for all infants who test positive to HIV
- The study aims to estimate EID testing positivity (i.e. “yield”), HIV-positive infant case finding, ART linkage, initiation, and 3-month retention among HIV-infected infants/young children and,
- Is expected to describe the operational characteristics of integrating mobile POC EID testing with Alere™ q HIV-1/2 Detect into community-level HIV activities to inform scale up of this novel model
